A photoactivable natural product with broad antiviral activity against enveloped viruses including highly pathogenic coronaviruses

Archive ouverte

Meunier, Thomas | Desmarets, Lowiese | Bordage, Simon | Bamba, Moussa | Hervouet, Kévin | Rouillé, Yves | François, Nathan | Decossas, Marion | Sencio, Valentin | Trottein, François | Honora Tra Bi, Fézan | Lambert, Olivier | Dubuisson, Jean | Belouzard, Sandrine | Sahpaz, Sevser | Séron, Karin

Edité par CCSD ; American Society for Microbiology -

International audience. The SARS-CoV-2 outbreak has highlighted the need for broad-spectrum antivirals against coronaviruses (CoVs). Here, pheophorbide a (Pba) was identified as a highly active antiviral molecule against HCoV-229E after bioguided fractionation of plant extracts. The antiviral activity of Pba was subsequently shown for SARS-CoV-2 and MERS-CoV, and its mechanism of action was further assessed, showing that Pba is an inhibitor of coronavirus entry by directly targeting the viral particle. Interestingly, the antiviral activity of Pba depends on light exposure, and Pba was shown to inhibit virus-cell fusion by stiffening the viral membrane as demonstrated by cryo-electron microscopy. Moreover, Pba was shown to be broadly active against several other enveloped viruses, and reduced SARS-CoV-2 and MERS-CoV replication in primary human bronchial epithelial cells. Pba is the first described natural antiviral against SARS-CoV-2 with direct photosensitive virucidal activity that holds potential for COVID-19 therapy or disinfection of SARS-CoV-2 contaminated surfaces.

Suggestions

Du même auteur

Hyperforin, the major metabolite of St. John’s wort, exhibits pan-coronavirus antiviral activity

Archive ouverte | Raczkiewicz, Imelda | CCSD

International audience. Introduction:The COVID-19 pandemic caused by the SARS-CoV-2 virus has underscored the urgent necessity for the development of antiviral compounds that can effectively target coronaviruses. In...

Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology

Archive ouverte | Belouzard, Sandrine | CCSD

The fastest way to implement a treatment against a new rapidly emerging viral disease consists in screening the potential antiviral activity of drugs approved for human use. This has the advantage of shortening regulatory preclini...

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

Archive ouverte | Belouzard, Sandrine | CCSD

International audience. Drug repurposing has the advantage of shortening regulatory preclinical development steps. Here, we screened a library of drug compounds, already registered in one or several geographical are...

Chargement des enrichissements...